ArticleAnnals of hematology2022

Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection.

Panagiotis T Diamantopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.